Clinically aggressive early-onset pancreatic ductal adenocarcinoma with KRAS wild-type status: A case report
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) represents one of the most lethal and challenging gastrointestinal (GI) malignancies. Predominant driver mutations for this cancer include KRAS, which is present in >90% of cases, alongside inactivating mutations in vari... ...